Track topics on Twitter Track topics that are important to you
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research! We just got some good news from Abeona Therapeutics a few days ago, as its lead strategy EB-101 got breakthrough designation for a rare skin disorder. But that's not the only therapy in the ABEO pipeline.
Original Article: 3 Things In Biotech You Should Learn Today: September 5, 2017NEXT ARTICLE